IP Library › Granted Patent US 11,584,785
Granted Patent B2
US 11,584,785 · App. 16/866,361 · Granted Feb 21, 2023

C-peptides and proinsulin polypeptides comprising the same

Inventors: Amy Doerner (Vancouver, WA); Michael Cammarata (Vancouver, WA); Tyler Nusca (Portland, OR); Suzanne A. Sprunger (Port Ludlow, WA); Melissa Patterson (Portland, OR)
Assignee: ABSCI, LLC
C07K14/47C07K14/62C12N9/485C12N9/96C12Y304/17002C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,584,785
App. No.
16/866,361
Granted
Feb 21, 2023
Kind
B2
Abstract

A connecting polypeptide has SEQ ID NO:73. A proinsulin polypeptide includes a mature insulin A-chain, a mature insulin B-chain, and a connecting peptide comprising SEQ ID NO: 73 linking the mature A-chain and the mature B-chain, wherein the connecting peptide is not a native human proinsulin C-peptide. The proinsulin polypeptides according to the invention can be made in high titers and in high purity.

Claims (30)

1. A connecting polypeptide comprising SEQ ID NO:73.

2. A proinsulin polypeptide comprising:

a mature insulin A-chain;

a mature insulin B-chain; and

a connecting peptide comprising SEQ ID NO:73 linking the mature A-chain and the mature B-chain, wherein the connecting peptide is not a native human proinsulin C-peptide.

3. The proinsulin polypeptide of claim 2 , wherein the mature insulin A-chain is selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:6.

4. The proinsulin polypeptide of claim 3 , wherein the mature insulin A-chain comprises SEQ ID NO:6.

5. The proinsulin polypeptide of claim 2 , wherein the mature insulin B-chain is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9.

6. The proinsulin polypeptide of claim 5 , wherein the mature insulin B-chain comprises SEQ ID NO:7.

7. The proinsulin polypeptide of claim 2 , wherein the proinsulin polypeptide lacks a signal peptide.

8. The proinsulin polypeptide of claim 2 , further comprising a carboxypeptidase B propeptide coupled to the N-terminal residue of the mature insulin B-chain, the carboxypeptidase B propeptide selected from the group consisting of SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, and SEQ ID NO:36.

9. The proinsulin polypeptide of claim 8 , wherein the carboxypeptidase B propeptide comprises SEQ ID NO:36.

10. The proinsulin polypeptide of claim 2 , further comprising a propeptide coupled to the N-terminal residue of the mature insulin B-chain, wherein the propeptide is SEQ ID NO:37.

11. An expression construct comprising a polynucleotide sequence encoding the insulin polypeptide of claim 2 .

12. A host cell comprising the expression construct of claim 11 .

13. A proinsulin polypeptide comprising:

a mature insulin A-chain comprising SEQ ID NO:6;

a mature insulin B-chain comprising SEQ ID NO:7; and

a connecting peptide comprising SEQ ID NO: 73 linking the mature A-chain and the mature B-chain, wherein the connecting peptide is not a native human proinsulin C-peptide.

14. The proinsulin polypeptide of claim 13 , wherein the proinsulin polypeptide lacks a signal peptide.

15. The proinsulin polypeptide of claim 13 , further comprising a carboxypeptidase B propeptide coupled to the N-terminal residue of the mature insulin B-chain, the carboxypeptidase B propeptide selected from the group consisting of SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, and SEQ ID NO:36.

16. The proinsulin polypeptide of claim 15 , wherein the carboxypeptidase B propeptide comprises SEQ ID NO:36.

17. An expression construct comprising a polynucleotide sequence encoding the insulin polypeptide of claim 13 .

18. A host cell comprising the expression construct of claim 17 .

19. A proinsulin polypeptide comprising:

a mature insulin A-chain comprising SEQ ID NO:6;

a mature insulin B-chain comprising SEQ ID NO:7;

a connecting peptide comprising SEQ ID NO:73 linking the mature A-chain and the mature B-chain, wherein the connecting peptide is not a native human proinsulin C-peptide; and

a carboxypeptidase B propeptide coupled to the N-terminal residue of the mature insulin B-chain, the carboxypeptidase B propeptide comprising SEQ ID NO:36.

20. The proinsulin polypeptide of claim 19 , wherein the proinsulin polypeptide lacks a signal peptide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2022
From: ABSCI, LLC
To: ABSCI CORPORATION
Reel/Frame 061336/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2022
From: DOERNER, AMY; CAMMARATA, MICHAEL; NUSCA, TYLER; SPRUNGER, SUZANNE A.; PATTERSON, MELISSA
To: ABSCI, LLC
Reel/Frame 060169/0162 →
Continuity (3)
Continuation PCTUS2019052998 · Sep 25, 2019
Provisional Application 62735861 · Sep 25, 2018
Related Publication 20200299343A1 · Sep 24, 2020
Cited By (1)
US 12,473,370